References
- McPherson G AD, Benjamin I S., Boobis A R., Blumgart L H. Antipyrine elimination in patients with obstructive jaundice: A predictor of outcome. Am J Surg 1985; 149: 140–3
- Villenueuve J-P, Infante-Rivard C, Ampelas M, Pomier-Layrargues G, Huet P M., Marleau D. Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology 1986; 5: 928–31
- Tengström B. An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic acids in hepatobiliary diseases. Scand J Clin Lab Invest 1966; 18(Suppl. 92)132
- Lindskov J. The quantitative liver function as measured by the galactose elimination capacity. Acta Med Scand 1982; 212: 295–302
- Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest 1966; 92(Suppl.)118–25
- Tygstrup N. Assessment of prognosis in fulminant hepatic failure. Sem in Liver Dis 1986; 6: 129–37
- Albers I H., Hartmann J B., Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989; 24: 269–76
- Marchesini G, Fabbri A, Bugianesi E, Bianchi G P., Marchi E, Zoli M, Pisi E. Analysis of the deterioration rates of liver function in cirrhosis, based on galactose elimination capacity. Liver 1990; 10: 65–71
- Millikan W J., Henderson J M., Stewart M T., Warren W D., Marsh J W., Galloway J R., Jennings H, Kavasaki S, Dodson T F., Perlino C A., Hertzler G L., Hooks M A., Smith S L., Moore P B. Change in hepatic function, hemodynamics and morphology after liver transplant. Physiological effect of therapy. Ann Surg 1989; 209: 513–25